XML 44 R23.htm IDEA: XBRL DOCUMENT
v3.19.2

Inventories (Tables) | 12 Months Ended
--- | ---
Apr. 30, 2019
Inventory Disclosure [Abstract] |
Summary of Inventories | Inventories consisted of the following at April 30 :
(in thousands) | 2019 | 2018
Finished goods | $ | 4,139 |  | $ | 4,987 |
Work-in-process | 2,179 |  | 2,393 |
Materials and components | 10,888 |  | 11,169 |
Total inventories | $ | 17,206 |  | $ | 18,549 |
Summary of Impact of Adoption of New Accounting Principle in Financial Statements | The following table summarizes the impact of adopting ASC 606 on the Company's consolidated statement of operations:
| Twelve Months Ended April 30, 2019
| ($ in thousands, except per share amounts)
| As Reported |  | Adjustments |  | Balance Without Adoption of ASC 606
Net sales | $ | 146,550 |  |  | $ | (1,226 | ) |  | $ | 145,324 |
Cost of products sold | 121,231 |  |  |  | (403 | ) |  |  | 120,828 |
Gross profit | 25,319 |  |  |  | (823 | ) |  |  | 24,496 |
Operating expenses | 23,207 |  |  |  | (35 | ) |  |  | 23,172 |
Operating earnings | 2,112 |  |  |  | (788 | ) |  |  | 1,324 |
Other income | 389 |  |  |  | — |  |  |  | 389 |
Interest expense | (367 | ) |  |  | — |  |  |  | (367 | )
Earnings before income taxes | 2,134 |  |  |  | (788 | ) |  |  | 1,346 |
Income tax expense | 446 |  |  |  | (182 | ) |  |  | 264 |
Net earnings | 1,688 |  |  |  | (606 | ) |  |  | 1,082 |
Net earnings attributable to the noncontrolling interest | 159 |  |  |  | — |  |  |  | 159 |
Net earnings attributable to Kewaunee Scientific Corporation | $ | 1,529 |  |  | $ | (606 | ) |  | $ | 923 |
Basic Earnings Per Share | $ | 0.56 |  |  | $ | (0.22 | ) |  | $ | 0.34 |
Diluted Earnings Per Share | $ | 0.55 |  |  | $ | (0.22 | ) |  | $ | 0.33 |
The following table summarizes the impact of adopting ASC 606 on the Company’s consolidated balance sheet:
| April 30, 2019
| ($ in thousands)
| As Reported |  | Adjustments |  | Balance Without Adoption of ASC 606
Assets |  |  |  |  |
Receivables, less allowances |  | 33,259 |  |  |  | (3,354 | ) |  |  | 29,905 |
Inventories |  | 17,206 |  |  |  | 2,331 |  |  |  | 19,537 |
Total Current Assets |  | 65,357 |  |  |  | (1,023 | ) |  |  | 64,334 |
Total Assets | $ | 87,223 |  |  | $ | (1,023 | ) |  | $ | 86,200 |
Liabilities and Stockholders’ Equity |  |  |  |  |
Accounts payable |  | 15,190 |  |  |  | (59 | ) |  |  | 15,131 |
Deferred revenue |  | 1,599 |  |  |  | 117 |  |  |  | 1,716 |
Other accrued expenses |  | 1,510 |  |  |  | (258 | ) |  |  | 1,252 |
Total Current Liabilities |  | 32,733 |  |  |  | (200 | ) |  |  | 32,533 |
Total Liabilities |  | 39,520 |  |  |  | (200 | ) |  |  | 39,320 |
Total Kewaunee Scientific Corporation Stockholders’ Equity |  | 47,100 |  |  |  | (823 | ) |  |  | 46,277 |
Total Stockholders’ Equity |  | 47,703 |  |  |  | (823 | ) |  |  | 46,880 |
Total Liabilities and Stockholders’ Equity | $ | 87,223 |  |  | $ | (1,023 | ) |  | $ | 86,200 |
The following table summarizes the effect of the change in method of accounting on the Company's prior consolidated statement of operations:
| Twelve Months Ended April 30, 2018 |  | Effect of Accounting Change |  | Twelve Months Ended April 30, 2018
(in thousands, except per share data) | As Previously Reported |  | LIFO/FIFO |  | As Adjusted
Cost of products sold |  | 126,030 |  |  | (139 | ) |  | 125,891 |
Gross profit |  | 32,020 |  |  | 139 |  |  | 32,159 |
Earnings from continuing operations before income taxes |  | 9,480 |  |  | 139 |  |  | 9,619 |
Income tax expense |  | 4,115 |  |  | 46 |  |  | 4,161 |
Net earnings |  | 5,365 |  |  | 93 |  |  | 5,458 |
Net earnings attributable to Kewaunee Scientific Corporation | $ | 5,188 |  | $ | 93 |  | $ | 5,281 |
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders |  |  |  |
Basic | $ | 1.91 |  | $ | 0.03 |  | $ | 1.94 |
Diluted | $ | 1.87 |  | $ | 0.03 |  | $ | 1.90 |
The following table summarizes the effect of the change in method of accounting on the Company's prior consolidated balance sheet:
| April 30, 2018 |  |  | Effect of Accounting Change |  |  | April 30, 2018
(in thousands) | As Previously Reported |  |  | LIFO/FIFO |  |  | As Adjusted
Inventory | $ | 17,662 |  |  | $ | 887 |  |  | $ | 18,549 |
Total Current Assets |  | 63,504 |  |  |  | 887 |  |  |  | 64,391 |
Deferred income taxes |  | 2,031 |  |  |  | (162 | ) |  |  | 1,869 |
Total Other Assets |  | 6,193 |  |  |  | (162 | ) |  |  | 6,031 |
Total Assets | $ | 84,358 |  |  | $ | 725 |  |  | $ | 85,083 |
Liabilities and Stockholders' Equity |  |  |  |  |  |  |
Other accrued expenses | $ | 2,062 |  |  | $ | 54 |  |  | $ | 2,116 |
Total Current Liabilities |  | 27,562 |  |  |  | 54 |  |  |  | 27,616 |
Total Liabilities |  | 36,837 |  |  |  | 54 |  |  |  | 36,891 |
Retained earnings |  | 43,165 |  |  |  | 671 |  |  |  | 43,836 |
Total Kewaunee Scientific Corporation Stockholders' Equity |  | 47,059 |  |  |  | 671 |  |  |  | 47,730 |
Total Equity |  | 47,521 |  |  |  | 671 |  |  |  | 48,192 |
Total Liabilities and Stockholders' Equity | $ | 84,358 |  |  | $ | 725 |  |  | $ | 85,083 |
The following table summarizes the effect of the change in method of accounting on the Company's prior consolidated cash flow:
|  | Twelve Months Ended April 30, |  | Effect of Accounting Change |  | Twelve Months Ended April 30,
|  | 2018 |  |  | 2018
| (in thousands) | As Previously Reported |  | LIFO/FIFO |  | As Adjusted
| Net earnings | $ | 5,365 |  |  | $ | 93 |  |  | $ | 5,458 |
| Change in assets and liabilities: |  |  |  |  |  |  |  |
| Inventories |  | (2,727 | ) |  |  | (139 | ) |  |  | (2,866 | )
| Accounts payable and other accrued expenses |  | 4,560 |  |  |  | 46 |  |  |  | 4,606 |
| Net cash provided by operating activities | $ | 3,183 |  |  | $ | — |  |  | $ | 3,183 |
Certain amounts in the Company’s consolidated statement of operations for the twelve months ended April 30, 2019 under the former LIFO method would have been as follows :
| Twelve Months Ended April 30, 2019
(in thousands, except per share amounts) | As Reported Under FIFO |  | Adjustments |  | As Computed Under LIFO
Cost of products sold | $ | 121,231 |  |  | $ | 444 |  |  | $ | 121,675 |
Income tax expense | 446 |  |  | (104 | ) |  | 342 |
Net earnings | 1,688 |  |  | (340 | ) |  | 1,348 |
Net earnings attributable to Kewaunee Scientific Corporation | $ | 1,529 |  |  | $ | (340 | ) |  | $ | 1,189 |
Net earnings per share attributable to Kewaunee Scientific Corporation stockholders |  |  |  |  |
Basic | $ | 0.56 |  |  | $ | (0.12 | ) |  | $ | 0.44 |
Diluted | $ | 0.55 |  |  | $ | (0.12 | ) |  | $ | 0.43 |
Certain amounts in the Company’s consolidated statement of cash flows for the twelve months ended April 30, 2019 would h ave been as follows under the former LIFO method:
| Twelve Months Ended April 30, 2019
(in thousands) | As Reported Under FIFO |  | Adjustments |  | As Computed Under LIFO
Net earnings | $ | 1,688 |  |  | $ | (340 | ) |  | $ | 1,348 |
Change in assets and liabilities: |  |  |  |  |
Inventories | 456 |  |  | 444 |  |  | 900 |
Other, net | (1,685 | ) |  | (104 | ) |  | (1,789 | )
Net cash provided by operating activities | $ | 2,490 |  |  | $ | — |  |  | $ | 2,490 |
Certain amounts in the Company’s consolidated balance sheet as of April 30, 2019 would have been as follows under the former LIFO method:
| April 30, 2019
(in thousands) | As Reported Under FIFO |  | Adjustments |  | As Computed Under LIFO
Inventories | $ | 17,206 |  |  | $ | (1,331 | ) |  | $ | 15,875 |
Total Current Assets | 65,357 |  |  | (1,331 | ) |  | 64,026 |
Deferred Income Taxes | 1,829 |  |  | 156 |  |  | 1,985 |
Prepaid Expenses and Other Assets | 3,736 |  |  | 164 |  |  | 3,900 |
Total Assets | 87,223 |  |  | (1,011 | ) |  | 86,212 |
Retained Earnings | 43,552 |  |  | (1,011 | ) |  | 42,541 |
Total Kewaunee Scientific Corporation Stockholders’ Equity | 47,100 |  |  | (1,011 | ) |  | 46,089 |
Total Stockholders’ Equity | 47,703 |  |  | (1,011 | ) |  | 46,692 |
Total Liabilities and Stockholders’ Equity | $ | 87,223 |  |  | $ | (1,011 | ) |  | $ | 86,212 |

X
- References No definition available. + Details
Name: | us-gaap_InventoryDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(c)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(6)(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 + Details
Name: | us-gaap_ScheduleOfInventoryCurrentTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e765-108305 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.10-01.(b)(6)) -URI http://asc.fasb.org/extlink&oid=27015980&loc=d3e46468-122699 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22580-107794 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 270 -SubTopic 10 -Section 45 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=109236672&loc=d3e725-108305 Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794 + Details
Name: | us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration